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Here, we report a screening platform for assessment of the cytotoxic potential of individual 
natural killer (NK) cells within larger populations. Human primary NK cells were distributed 
across a silicon–glass microchip containing 32,400 individual microwells loaded with tar-
get cells. Through fluorescence screening and automated image analysis, the numbers 
of NK and live or dead target cells in each well could be assessed at different time 
points after initial mixing. Cytotoxicity was also studied by time-lapse live-cell imaging in 
microwells quantifying the killing potential of individual NK cells. Although most resting 
NK cells (≈75%) were non-cytotoxic against the leukemia cell line K562, some NK cells 
were able to kill several (≥3) target cells within the 12-h long experiment. In addition, the 
screening approach was adapted to increase the chance to find and evaluate serial killing 
NK cells. Even if the cytotoxic potential varied between donors, it was evident that a 
small fraction of highly cytotoxic NK cells were responsible for a substantial portion of the 
killing. We demonstrate multiple assays where our platform can be used to enumerate 
and characterize cytotoxic cells, such as NK or T cells. This approach could find use 
in clinical applications, e.g., in the selection of donors for stem cell transplantation or 
generation of highly specific and cytotoxic cells for adoptive immunotherapy.
Keywords: nK cells, cytotoxicity, single cell analysis, microchip, screening, microscopy, fluorescence, immune 
synapse
inTrODUcTiOn
Cytotoxic effector lymphocytes, such as natural killer (NK) cells and T cells, are important for 
immune defense against cancer and viral infections, the traits that have made these cells valuable 
in adoptive cell therapy. However, their activity is also associated with detrimental conditions, such 
as autoimmunity or graft-versus-host disease (GVHD), after allogeneic hematopoietic stem cell 
transplantation (HSCT). Upon activation, both effector cell types are able to kill abnormal cells 
through release of toxic granules containing perforin and granzymes at the tight intercellular contact 
formed at the immune synapse (1, 2).
NK cell activation relies on a balance between activating and inhibitory signals from a range of 
cell surface receptors recognizing ligands on the target cell surface. Inhibitory signals are mediated 
2Guldevall et al. Screening in Microwells
Frontiers in Immunology | www.frontiersin.org April 2016 | Volume 7 | Article 119
by MHC class I proteins that are expressed by most normal cells. 
However, some infections and transformations lead to down-
regulation of MHC class I and/or upregulation of activating 
NK cell ligands rendering them susceptible to NK cell attack. 
A functional NK cell repertoire is generated through cellular 
education, resulting in a heterogeneous NK cell population with 
varying capacity to respond to stimuli (3–6). Little is known 
about the functional consequences of education and how this 
relates to the individual NK cell cytotoxic response observed. 
However, clinical trials using NK cells from haploidentical 
donors for cell therapy have shown encouraging results indicat-
ing that interindividual differences in NK cell recognition and 
responsiveness can be used to treat disease (7). Importantly, 
these studies also established a link between the number of 
alloreactive NK cells in the graft and patient survival. However, 
one limitation is that there are few efficient methods to enumer-
ate the fraction of cytotoxic NK cells from a donor sample for 
a given donor–recipient pair. Thus, new methods to quantify 
the fraction of alloreactive NK cells and cytolytic potential of 
individual NK cells could be valuable for the process of selecting 
donors for therapy.
During the past years, several new tools for single cell 
analysis have been developed, and some of those have been 
used to dissect T or NK cell heterogeneity in terms of pheno-
type, cytotoxicity, or cytokine release (8–22). Here, we use a 
previously reported microchip platform (23, 24) to screen the 
cytotoxic response of human peripheral blood NK cells against 
transformed human cells. This tool complements currently 
used population- and flow-based techniques as it quantifies the 
fraction of cytotoxic cells and resolves the cytotoxic potential 
of individual cells. We find donor-to-donor differences in the 
fractions of cytotoxic NK cells, a dependence on the choice of 
target cell and significant heterogeneity in cytotoxic capacity of 
individual cells.
MaTerials anD MeThODs
Microchip and holder
Fabrication of microchips was performed as previously described 
(24). Briefly, microwell layout was defined by lithography fol-
lowed by deep-reactive ion etching and surface oxidation growth. 
The microwells were sealed at one end by anodic bonding of a 
thin (175 μm) glass to the silicon, and the wafer was diced into 
individual microchips (22 mm × 22 mm × 475 μm). During load-
ing and imaging, the microchip was placed in a custom-made 
holder with plastic lid held together by four magnets. To reduce 
evaporation, but maintain oxygen and carbon dioxide exchange, 
a 35-mm Petri dish lid was placed over the holder lid. Before cell 
seeding, the chip was covered with cell medium and primed in 
vacuum to allow liquid to enter the wells.
cells and reagents
All experiments with human cells were performed according 
to local ethics regulations. Human NK cells were isolated from 
PBMCs of anonymous healthy donors by negative selection 
using the NK cell Isolation Kit (Miltenyi Biotec) according to 
manufacturer’s instructions. Freshly isolated NK cells were 
maintained in RPMI 1640 cell culture media (Sigma-Aldrich) 
supplemented with 10% human serum (Blood bank, Karolinska 
Hospital), 50 U/mL penicillin–streptomycin, 2 mM l-glutamine, 
1× non-essential amino acids, 1 mM sodium pyruvate (all from 
Sigma-Aldrich), and naive NK cells were used within 2 days. For 
the activation of NK cells, 200  U/mL of IL-2 (Peprotech) was 
added to the cell culture media, and the NK cells were then used 
within 6–9 days. The NK cell purity of the isolated cell population 
was >95% CD3−CD56+ as confirmed by flow cytometry. The leu-
kemia cell line K562 and human embryonic kidney (HEK)293T 
cells were cultured in RPMI 1640 media supplemented with 10% 
FBS, 50 U/mL penicillin–streptomycin, and 2 mM l-glutamine 
(all from Sigma-Aldrich).
For fluorescent staining before imaging, cells were washed, 
incubated with the appropriate dye dissolved in RPMI 1640 for 
10 min at 37°C, washed, and used for experiments. Final staining 
concentrations were 0.5–1.0  μM for CellTrace Calcein Green 
AM, 5  μM FarRed DDAO-SE (target cells), and 0.4–0.6  μM 
CellTrace Calcein Red-Orange AM (NK cells) (all dyes were 
from Invitrogen). The family of CellTrace calcein dyes freely dif-
fuses over the cell membrane. Once inside the cell, cytoplasmic 
enzymes hydrolyze the dye, causing the polarized product to leak 
out much more slowly than it entered. Calcein dyes give a uni-
form fluorescent cytoplasmic staining as long as the membrane 
is intact making them suitable for detection of cell viability. On 
the other hand, DDAO forms covalent bonds to primary amines 
present everywhere in the cell and remains detectable after cell 
death has occurred.
Microscopy and image analysis
Images were obtained at 10× magnification using any of four 
inverted confocal microscopes (Olympus IX81, Zeiss LSM 510 
Meta, Zeiss LSM 780, or Zeiss LSM 880) equipped with environ-
mental chambers maintained at 37°C, 5% CO2, and motorized 
stages enabling automatic screening. Screening the whole chip 
required acquisition of 400 separate images, taking ~45  min. 
Often, analysis was performed only on parts of the chip.
The number of effector cells, as well as live and dead target 
cells in each well, was quantified either automatically by a 
software routine developed in Matlab or by a combination of 
automatic and manual analysis. Briefly, the image analysis soft-
ware first identified the microwells using the transilluminated 
channel. Thresholds were applied to the fluorescence channels. 
Remaining objects were convolved with a Gaussian chosen to be 
of approximately the same size as the cells to improve circularity 
and to simplify separation of clustered cells. An algorithm based 
on the circular Hough transform (25) was applied to search for 
roughly circular objects. NK cells, due to their irregular non-cir-
cular morphology, were instead identified using an algorithm for 
finding connected components corresponding to single NK cells 
(25). The classification of live and dead target cells was performed 
by comparing the green (calcein green) and red (DDAO) fluores-
cent intensity from each individual target cell. The threshold was 
set either manually or automatically by selecting the threshold 
that maximizes the mean of the pairwise Euclidean distances 
between the intensity values of live and dead targets cells. The 
FigUre 1 | Microchip screening platform. (a) Holder (i), microchip (ii), PDMS gasket (iii), and plastic lid (iv). (B) Detailed view of the silicon–glass microchip 
showing photograph of the whole chip (top) containing 32,400 microwells arranged in 20 × 20 subunits each containing 9 × 9 microwells (bottom). The bottom 
image is produced by confocal fluorescence imaging of microwells filled with fluorescent solution (pink) and reflection from the silicon–glass interface (green).  
(c) Flow chart outlining the screening process. (D) Example RGB-transmitted light composite image (i) from an individual well containing one live target cell (green), 
one dead target cell (red), and one NK cell (blue). Scale bar represent 10 μm. The automated software-detected microwell is shown in (ii). The blue channel (iii) 
shows the calcein orange-stained NK cell, and the green channel (iv) shows the calcein green-stained target cell. The red channel (v) contains both weak DDAO 
fluorescence from the live target cell and stronger DDAO fluorescence from the dead target cell. The filtered image of the target cells (vi) is used for the automated 
software detection of live and dead target cells shown as circles in (vii).
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software then returned a numbered map of the detected wells and 
the number of objects in each well, together with a heuristically 
chosen figure of goodness describing the chances that the soft-
ware had made a correct determination of the number and status 
of cells. This figure was based on several factors, such as large 
numbers of cells in a single well, the existence of large contiguous 
objects (likely to be multiple cells), bright objects that could not 
be identified as cells, and amount of overlap of identified cells. 
Accuracy of the automatic counting was decreased at screens 
performed at later times due to decreased fluorescence intensity 
(mainly affecting the NK cells) and debris from dying target 
cells in some of the wells. In such cases, manual counting was 
performed.
statistical analysis
Yates Chi-square test was used to evaluate significance. p-Values 
above 0.05 were considered not significant (n.s.), whereas 
p-values below 0.05 were considered significant and marked by 
stars (0.01 < p < 0.05 marked as *, 0.001 ≤ p ≤ 0.01 marked as **, 
and p < 0.001 marked as ***).
resUlTs anD DiscUssiOn
Microchip cytotoxicity assay
The microchip platform consisted of a silicon–glass microchip 
held in place by an aluminum plate, a polydimethylsiloxane 
(PDMS) gasket, and a plastic lid, and it was designed to fit in 
a conventional inverted fluorescence or confocal microscope 
(Figure  1A). The microchip contained 32,400 individual wells 
(≈50 μm ×  50 μm) arrayed to facilitate screening with a 10× 
objective (Figure 1B). Deep wells (300 μm) prevented cells from 
escaping the wells, and thin glass at the bottom (175 μm) allowed 
high-resolution imaging (18, 24).
To assess single cell cytotoxicity, NK cells were labeled with 
the fluorescent viability dye calcein orange and target cells with 
calcein green and DDAO. This allowed detection of live NK cells 
and distinguishing live from dead target cells (Figures  1C,D). 
Target cells were seeded on the chip and allowed to sediment in 
to the microwells, then NK cells were added creating an E:T ratio 
of ≈1:2.5–5, with the higher E:T ratio used to screen for serial 
killing NK cells. The chip was then screened to assess the number 
of effector cells and live/dead target cells in each well at the begin-
ning of the experiment. In addition, in experiments requiring 
more precise enumeration of NK cell-mediated killing events, a 
prescreen of seeded target cells was acquired before seeding the 
effector cells. The cells were then left to incubate under physi-
ological conditions (typically for 6 h) to allow effector-mediated 
lysis to occur before the chip was screened again. The incubation-
screening cycle was repeated until the experiment was stopped. 
The number of effector cells and live/dead target cells was counted 
with the in-house automatic counting routine, and the cytotoxic 
potential of effector cells was assessed.
screening of nK-Mediated Killing of 
Tumor cells
To investigate NK-mediated killing in the microchip, human 
peripheral blood NK cells were isolated from healthy donors and 
activated in IL-2 for 6–9  days. On the day of experiment, NK 
cells were labeled and mixed on the chip with labeled target cells. 
Target cells used were either the cell line K562 originally derived 
from a human patient chronic myeloid leukemia (CML) in blast 
crisis (26) or HEK293T cells. Cytolytic and non-cytolytic NK 
FigUre 2 | cytotoxicity screening of il-2-activated human peripheral 
blood nK cells. (a) Examples of images acquired at times 0, 6, and 12 h of 
wells containing single NK cell and three to four K562 (top) or HEK293T 
(bottom) target cells. Target cell death was observed by loss of green 
fluorescence from calcein and increased red fluorescence from DDAO. The 
NK cells shown in the top two rows both kill three target cells during the assay, 
whereas the NK cell shown at the bottom row is non-cytolytic. Scale bars 
represent 15 μm. Images have been resampled and adjusted for brightness 
and contrast. (B) Fraction of cytotoxic NK cells assessed after 6 and 12 h with 
HEK293T target cells (left, three separate NK cell donors, ntotal = 997) or K562 
target cells (right, three separate NK cell donors, ntotal = 1808). Spontaneous 
target cell death is shown in gray (ntotal, HEK293T = 2423, ntotal, K562 = 3467). Data 
points from individual donors are connected by dashed lines and mean values 
are shown with red bars. The presented data are based on target cells dying 
during the assay, i.e., death events scored between the screens at T0h, T6h, 
and T12h. Statistical analysis was performed on total number of observations 
for each cell type and significance is indicated by red stars or letters.
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cells were observed against both types of target cells (examples 
in Figure 2A). To assess the level of NK killing, wells containing 
single NK cells and at least one live target cell at time T0h were 
analyzed after 6 (T6h) and 12 h (T12h), and the number of wells 
where target cell death had occurred was counted. NK cells from 
three donors were tested against both types of target cell. Target 
cell death was observed in ≈20–70% of wells for HEK293T and 
in ≈30–70% of wells for K562. Spontaneous target cell death was 
detected in only a few percent of the wells (Figure 2B). We did 
note a background level of target cell death seen as a fraction 
(~5–7%) of the target cells being dead already at T0h (Figure S1A 
in Supplementary Material). This fraction was higher in wells 
containing NK cells (≈10–15%) (Figure S1B in Supplementary 
Material), due to NK cell-mediated killing occurring before 
the first imaging was completed at T0h. As a consequence, the 
fraction of cytolytic NK cells presented in Figure 2B is slightly 
underestimated. The data showed that the fraction of cytolytic 
NK cells was somewhat higher for the K562 target cells and that 
the donor-to-donor differences seemed to be more pronounced 
for HEK293T cells. The fractions of cytolytic NK cells increased 
marginally between T6h and T12h, indicating that not all lysis 
was completed during the first part of the assay (Figure  2B). 
Together, these experiments show that this screening approach 
allows the fraction of lytic effector cells within populations to be 
determined, differences between donors or types of target cells 
to be detected, and the change of NK cell-mediated lysis to be 
monitored over time.
Time-lapse imaging of nK cell immune 
surveillance
Time-lapse imaging of human NK cells interacting with K562 cells 
in microwells was also performed. K562 target cells followed by 
resting (non-activated) NK cells were seeded across the microchip 
at an E:T ratio of ≈1:3 and imaged at 10 parallel positions, each 
covering 81 microwells, every 3 min for 12 h (examples of time-
lapse sequences can be found in Movies S1–S3 in Supplementary 
Material). From three independent experiments, 1295 NK cells 
and 3323 target cells distributed in 775 microwells were analyzed 
based on the criteria that only microwells containing at least 1 
NK and 1 target cell were studied. We scored 425 killing events 
committed by 326 NK cells, indicating that ≈25% of the NK cells 
exhibited cytotoxicity. As expected, this number is lower than 
what was found for IL-2-activated NK cells (Figure 2). In wells 
with single NK cells and ≥3 live target cells, 72% of the NK cells 
did not kill any target cells, whereas the remaining cells were 
cytotoxic (Figure 3A). A small fraction of NK cells (≈1%) was 
scored as “serial killers,” as they killed three or more target cells 
during the assay. One NK cell was observed to kill as many as eight 
target cells (Figure  3B; Movie S3 in Supplementary Material). 
Although serial killers have been described before among 
IL-2-activated human peripheral blood NK cells (16, 17, 27), 
the phenomenon has been less studied among resting NK 
cells. We currently know very little about these NK cells with 
extraordinary lytic potential, partly because they are “invisible” in 
population-based methods or in flow cytometry where high cell 
surface expression of CD107a+ is used as a sign for degranulation 
and cytotoxicity after stimulation with target cells. Given that 
the fraction of serial killers under steady-state conditions is low, 
efficient methods for studying the response of single NK cells are 
needed to gain better understanding of these cells.
FigUre 3 | single-cell level cytotoxicity of resting human polyclonal 
nK cells revealed by time-lapse imaging in microwells. (a) Frequency 
of NK cells killing between 0 and ≥3 target cells. Wells containing single NK 
cells and at least three live K562 target cells were selected for analysis. 
Presented data are from four donors (black circles connected by dashed 
lines) with mean values shown by red bars (ntotal = 322). (B) Time-lapse 
sequence showing a serial killer that eliminates 8 target cells in the 12-h 
experiment. The rows show from top to bottom: RGB composite of 
fluorescent channels for NK (blue) and target cells (green and red), 
transmitted light, calcein orange NK channel, target cell calcein green, and 
target cell DDAO channels. Each column represents different time points 
(hours:minutes). Scale bars represent 15 μm. Images have been resampled 
and adjusted for brightness and contrast.
FigUre 4 | enumeration of killing potential and assessment of nK 
serial killing. Distribution of NK cells killing 0, 1, 2, 3, 4, or ≥5 K562 target 
cells at T6h (black bars) and T12h (gray bars). Wells were selected for analysis 
based on having a single live NK cell at T0h (and ≤1 live NK cell at later time 
points) and ≥5 live target cells before NK cell seeding (T-NK).
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assessing serial Killing by nK cells
Finally, we decided to further evaluate the cytolytic potential of 
individual NK cells by adapting the assay toward accurate enumera-
tion of killing events and detection of NK serial killers. The screen-
ing assay was adapted in three ways. (1) In the first cytotoxicity 
screening, it was observed that some NK cells killed targets before 
imaging at T0h (Figure S1B in Supplementary Material); therefore, a 
prescreen of the seeded K562 cells were acquired prior to addition 
of the NK cells (T-NK). (2) The seeding density of target cells was 
doubled in order to give most NK cells a chance to kill multiple 
target cells. (3) Only wells that contained ≥5 live target cells at T-NK 
and a single live NK cell were selected for further analysis.
Pooling data from three individual experiments of IL-2-
activated NK cells and K562 target cells showed that the fraction 
of NK cells gradually decreased with the number of killing events 
scored (Figure 4). Comparing the screens performed at T6h and 
at T12h showed that the majority of killing took place during the 
first 6  h of the assay. However, as evident from the decreased 
population of NK cells killing zero target cells when comparing 
T6h and T12h, a small fraction of the NK cells did not perform their 
first kill until after 6 h. This could be caused by the requirement 
of initial NK–target cell interactions before activation and kill-
ing (28), but a contribution from spontaneous target cell death 
cannot be excluded. Interestingly, higher fractions of cytotoxic 
NK cells were observed in the experiments where the target cell 
density was higher. This is consistent with our previous report 
that high target cell density can increase the likelihood of NK cell 
cytotoxicity but could also be coupled to heterogeneity in target 
cells susceptibility or motility of the NK cell (16, 29).
Taken together, NK cells that killed three or more target cells 
were responsible for 70% of the killing, and from this cohort, 
the most potent NKs (killing ≥5 targets) were responsible for 
20–25% of the total target cell death. Thus, despite representing 
a minority of the total population, the serial killing NK cells play 
an important role in target cell elimination (17).
cOnclUsiOn
We report functional measurements allowing enumeration of 
cytotoxic cells and assessment of cytotoxic potential of individual 
cells in polyclonal populations of NK cells. The ability to monitor 
a single cell’s cytolytic capacity over time in a high throughput 
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fashion is an advancement on standard techniques, such as 
isotope release assays (chromium/europium) or some flow-
based methods, which perform bulk measurement of target cell 
death. While population measurements give a general overview, 
they fail to dissect how the sum of individual cellular responses 
contributes to the overall response. Flow-based CD107a release 
assays can yield single cell information on cellular degranulation 
but provides no information on, e.g., neither the number of target 
cells killed nor the temporal single cell history. On the flip side, the 
method presented here does require some technical know-how, 
is more laborious, and time consuming than population-based 
assays. These could be seen as limiting factors, e.g., clinical utility. 
However, this method offers a precise single cell tool, allowing 
small cell numbers to be observed over extended periods of time 
and seems especially useful when screening for rare events. We 
see these advantages as strong indicators of utility within hemat-
opoietic stem cell transplantation where small, to date difficult 
to detect, populations of cells drive clinically beneficial graft-
versus-leukemia effects or severe illness, such as GVHD. With a 
proof-of-concept, the clinical utility will outweigh the technical 
disadvantages and drive innovation and advancement toward an 
easier streamlined approach. Thus, we believe that the platform 
presented here, together with previously reported lab-on-a-chip 
tools, represent strong complements to flow- and population-
based assays for evaluating NK cytotoxicity.
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